402 related articles for article (PubMed ID: 25808833)
1. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
[TBL] [Abstract][Full Text] [Related]
3. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus.
Kurasawa K; Arai S; Owada T; Maezawa R; Kumano K; Fukuda T
Mod Rheumatol; 2010 Oct; 20(5):458-65. PubMed ID: 20490598
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
6. Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.
Moroncini G; Svegliati S; Grieco A; Cuccioloni M; Mozzicafreddo M; Paolini C; Agarbati S; Spadoni T; Amoresano A; Pinto G; Chen Q; Benfaremo D; Tonnini C; Senzacqua M; Alizzi S; Nieto K; Finke D; Viola N; Amico D; Galgani M; Gasparini S; Zuccatosta L; Menzo S; Müller M; Kleinschmidt J; Funaro A; Giordano A; La Cava A; Dorfmüller P; Amoroso A; Pucci P; Pezone A; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2024 Apr; 76(4):620-630. PubMed ID: 37975161
[TBL] [Abstract][Full Text] [Related]
7. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
Classen JF; Henrohn D; Rorsman F; Lennartsson J; Lauwerys BR; Wikström G; Rorsman C; Lenglez S; Franck-Larsson K; Tomasi JP; Kämpe O; Vanthuyne M; Houssiau FA; Demoulin JB
Arthritis Rheum; 2009 Apr; 60(4):1137-44. PubMed ID: 19333949
[TBL] [Abstract][Full Text] [Related]
9. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
10. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
11. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
Ueki A; Isozaki Y; Tomokuni A; Hatayama T; Ueki H; Kusaka M; Shiwa M; Arikuni H; Takeshita T; Morimoto K
Clin Exp Immunol; 2002 Sep; 129(3):556-61. PubMed ID: 12197899
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
Front Immunol; 2018; 9():428. PubMed ID: 29623076
[TBL] [Abstract][Full Text] [Related]
14. Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution.
Haddon DJ; Jarrell JA; Diep VK; Wand HE; Price JV; Tangsombatvisit S; Credo GM; Mackey S; Dekker CL; Baechler EC; Liu CL; Varma M; Utz PJ
Autoimmunity; 2015; 48(8):513-23. PubMed ID: 26333287
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization.
Tzioufas AG; Yiannaki E; Sakarellos-Daitsiotis M; Routsias JG; Sakarellos C; Moutsopoulos HM
Clin Exp Immunol; 1997 May; 108(2):191-8. PubMed ID: 9158085
[TBL] [Abstract][Full Text] [Related]
16. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.
Balada E; Simeón-Aznar CP; Ordi-Ros J; Rosa-Leyva M; Selva-O'Callaghan A; Pardos-Gea J; Fonollosa-Pla V; Vilardell-Tarrés M
Ann Rheum Dis; 2008 Jul; 67(7):1027-9. PubMed ID: 18272670
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
18. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
Boumba VA; Seferiadis K
J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.
Azzouz DF; Martin GV; Arnoux F; Balandraud N; Martin T; Dubucquoi S; Hachulla E; Farge-Bancel D; Tiev K; Cabane J; Bardin N; Chiche L; Martin M; Caillet EC; Kanaan SB; Harlé JR; Granel B; Diot E; Roudier J; Auger I; Lambert NC
PLoS One; 2016; 11(9):e0160283. PubMed ID: 27617966
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]